Oruka Therapeutics, Inc. (ORKA) Capital expenditures 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$209,000FY2025 · since FY2016: $12,000 → $209,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $209,000 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $2,000 | -95.3% |
| FY2021 | $43,000 | +126.3% |
| FY2020 | $19,000 | +375.0% |
| FY2019 | $4,000 | +0.0% |
| FY2018 | $4,000 | +33.3% |
| FY2017 | $3,000 | -75.0% |
| FY2016 | $12,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice